"Proteus mirabilis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.
| Descriptor ID |
D011513
|
| MeSH Number(s) |
B03.440.450.425.600.501 B03.660.250.150.590.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteus mirabilis".
Below are MeSH descriptors whose meaning is more specific than "Proteus mirabilis".
This graph shows the total number of publications written about "Proteus mirabilis" by people in this website by year, and whether "Proteus mirabilis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proteus mirabilis" by people in Profiles.
-
Mo S, Durrani AF, Safiullah Z, Kowalski RP, Jhanji V. Proteus mirabilis Keratitis: Risk Factors, Clinical Features, Treatment Outcomes, and Microbiological Characteristics. Cornea. 2021 Jun 01; 40(6):704-709.
-
Stull J, Bhat S, Miller AJ, Hoffman R, Wang ML. Treatment of Atypical Compartment Syndrome Due to Proteus Infection. Orthopedics. 2017 Jan 01; 40(1):e176-e178.
-
Karlowsky JA, Biedenbach DJ, Kazmierczak KM, Stone GG, Sahm DF. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC ?-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014. Antimicrob Agents Chemother. 2016 05; 60(5):2849-57.
-
Critchley IA, Sahm DF, Kelly LJ, Karlowsky JA. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli. Chemotherapy. 2003 May; 49(1-2):44-8.